Depreciation in USD of Barinthus Biotherapeutics plc. from 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Barinthus Biotherapeutics plc. quarterly/annual Depreciation history and change rate from 2020 to Q3 2025.
  • Barinthus Biotherapeutics plc. Depreciation for the quarter ending 30 Sep 2025 was $100K, a 85.7% decline year-over-year.
  • Barinthus Biotherapeutics plc. Depreciation for the twelve months ending 30 Sep 2025 was $3.1M, a 14.8% increase year-over-year.
  • Barinthus Biotherapeutics plc. annual Depreciation for 2024 was $2.6M, a 13% increase from 2023.
  • Barinthus Biotherapeutics plc. annual Depreciation for 2023 was $2.3M, a 109% increase from 2022.
  • Barinthus Biotherapeutics plc. annual Depreciation for 2022 was $1.1M, a 175% increase from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Barinthus Biotherapeutics plc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $3.1M $100K -$600K -85.7% 01 Jul 2025 30 Sep 2025 10-Q 07 Nov 2025
Q2 2025 $3.7M $1.2M +$500K +71.4% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 $3.2M $1.2M +$600K +100% 01 Jan 2025 31 Mar 2025 10-Q 07 May 2025
Q4 2024 $2.6M $600K -$100K -14.3% 01 Oct 2024 31 Dec 2024 10-K 20 Mar 2025
Q3 2024 $2.7M $700K $0 0% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2025
Q2 2024 $2.7M $700K +$200K +40% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025
Q1 2024 $2.5M $600K +$200K +50% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2025
Q4 2023 $2.3M $700K +$400K +133% 01 Oct 2023 31 Dec 2023 10-K 20 Mar 2025
Q3 2023 $1.9M $700K +$300K +75% 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2024
Q2 2023 $1.6M $500K +$300K +150% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 $1.3M $400K +$200K +100% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024
Q4 2022 $1.1M $300K 01 Oct 2022 31 Dec 2022 10-K 20 Mar 2024
Q3 2022 $400K 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 $200K 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023
Q1 2022 $200K 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023

Barinthus Biotherapeutics plc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $2.6M +$300K +13% 01 Jan 2024 31 Dec 2024 10-K 20 Mar 2025
2023 $2.3M +$1.2M +109% 01 Jan 2023 31 Dec 2023 10-K 20 Mar 2025
2022 $1.1M +$700K +175% 01 Jan 2022 31 Dec 2022 10-K 20 Mar 2024
2021 $400K +$192K +92.3% 01 Jan 2021 31 Dec 2021 10-K 24 Mar 2023
2020 $208K 01 Jan 2020 31 Dec 2020 10-K 25 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.